Orexigen Therapeutics, Inc. Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014
SAN DIEGO, May 8, 2014 /PRNewswire/ -- Orexigen® Therapeutics, Inc. /quotes/zigman/104573/delayed/quotes/nls/orex OREX +1.89% , a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for the first quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.